CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood ...

Cerus (CERS) announced the publication of a new recommendation from the German National Blood Advisory Committee, which recommends proactive measures, including pathogen inactivation such as Intercept ...

Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S. BCA member ...

Samsung Electronics forecasted strong artificial intelligence-driven demand for chips in the second half of this year, as it reported a more than 15-fold rise in its second-quarter operating profit.

Regulatory Approval Allows Company to Initiate Commercialization of the Illumination Device throughout the European Union CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (CERS) announced today ...